LIALDA PACKAGE INSERT PDF

Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney. Shire US Manufacturing Inc.: LIALDA is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Lialda (mesalamine).

Author: Mozahn Tegore
Country: French Guiana
Language: English (Spanish)
Genre: Career
Published (Last): 26 May 2009
Pages: 398
PDF File Size: 4.59 Mb
ePub File Size: 18.89 Mb
ISBN: 306-9-59286-393-5
Downloads: 93859
Price: Free* [*Free Regsitration Required]
Uploader: Gagore

Shire does not control the content of non-Shire Web sites, and this link does not constitute an endorsement by Shire of the site’s content. E—mail this list of questions for the doctor — to yourself, a friend or a loved one — by filling out the form below. Click “Cancel” to return or “OK” to continue. Please see our privacy policy for more information.

This site is intended solely for US residents and is governed solely by US laws and government regulations.

You may need to adjust your Internet properties within your Web browser software, such as Microsoft Internet Explorer or Mozilla Firefox. Tell your doctor if you: You must have JavaScript enabled on your computer to access this Web site feature.

E-mail to a Friend

Important Safety Information Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, lilda medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda.

  ACTEAL CRIMEN DE ESTADO PDF

Following Your Prescribed Treatment Plan.

The information contained in this section of the site is intended for Lialra health care professionals only. Cookies are required to use some elements of this Web site. While Shire US Inc. Click OK if you are a health care professional. If this happens to you, your doctor may tell you to stop taking Lialda. All content on this Web site, including text, images, graphics, sound files, and their arrangement, belongs to Shire and is protected by international copyright laws.

All fields are required.

All other intellectual property rights are reserved. Your doctor may check to see how your kidneys are working before starting Lialda and periodically while taking Lialda. Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda.

Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)

E-mail this page only. Kidney problems have been reported with medications that contain mesalamine, such as Lialda. For the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC. Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes. Please see Full Prescribing Information for Lialda mesalamine. In clinical studies of Lialda, inflammation inset the pancreas also occurred.

  ETHOSOMAL GEL PDF

Lialda is a prescription medication approved for the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC. See Full Important Safety Information. We encourage you to read the privacy policy of every Web site you visit.

See Additional Important Safety Information. This link will take you to a Web site maintained by a third party, who is responsible for its content and privacy policy. The content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites.

You are encouraged to report negative side lialdda of prescription drugs to the FDA. E-mail this page or Web site to a friend or loved one by filling out the form below. Please review Shire’s Privacy Policy.

Our privacy policy does not apply to this site. Find information about UC.